ALNY Stock Balance Sheets

Alnylam Pharmaceuticals Quarterly Balance Sheets Chart

Quarterly

Annual

Account Receivables

Cash and Cash Eq

Account Payables

Deferred Revenue

Long-Term Debt

Inventory

Alnylam Pharmaceuticals Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30

assets
current assets:
cash and cash equivalents	1,113,685,000	1,019,654,000	966,428,000	1,099,920,000	968,492,000	681,879,000	812,688,000	1,033,024,000	657,800,000	672,245,000	866,394,000	1,073,228,000	575,558,000	534,081,000	819,975,000	1,093,991,000	745,767,000	379,543,000	496,580,000	496,704,000	580,829,000	467,779,000	547,178,000	923,304,000	1,136,289,000	724,959,000	420,146,000	316,608,000	361,457,000	396,149,000	645,361,000	202,045,000	408,671,000	171,079,000	193,617,000	168,481,000	271,076,000	231,278,000	180,895,000	149,218,000	151,262,000	306,580,000	75,179,000	82,721,000	80,727,000	350,589,000	53,169,000	11,840,000	24,975,000	97,804,000	51,405,000	75,838,000	48,274,000	61,739,000	70,228,000	74,336,000	67,110,000	90,590,000	74,599,000	46,881,000	66,182,000	114,947,000	137,468,000	98,087,000	147,870,000	227,268,000	191,792,000	196,737,000	247,536,000	196,281,000	105,157,000	200,547,000	84,464,000	66,662,000	127,955,000	35,516,000	35,645,000	56,804,000	15,757,000	7,178,000	9,165,000	12,215,000	20,272,000	14,544,000	31,891,000
marketable debt securities	1,743,900,000	1,605,368,000	1,719,920,000	1,671,993,000	1,646,268,000	1,678,147,000	1,615,516,000	1,362,843,000	1,372,451,000	1,372,574,000	1,297,890,000	1,169,050,000	1,504,154,000	1,673,485,000	1,548,617,000	1,161,324,000	1,101,782,000	1,273,027,000	1,333,182,000	1,279,955,000	1,258,425,000	836,346,000	975,017,000	797,754,000	790,542,000	519,578,000	662,803,000	905,222,000	1,074,165,000
marketable equity securities		7,200,000	8,156,000	8,322,000	9,889,000	11,256,000	11,178,000	10,411,000	27,256,000	25,856,000	28,122,000	23,051,000	30,901,000	31,997,000	66,972,000	72,550,000	52,533,000	56,967,000	44,633,000	57,217,000	86,310,000	38,078,000	13,967,000				1,206,000	15,004,000	12,044,000
accounts receivable	567,112,000	418,035,000	405,308,000	353,852,000	309,481,000	321,377,000	327,787,000	325,445,000	220,635,000	219,434,000	237,963,000	184,513,000	142,271,000	156,533,000	198,571,000	141,064,000	146,587,000	110,626,000	102,413,000	79,118,000	69,115,000	75,572,000	43,011,000	48,109,000	30,739,000	33,801,000	18,760,000	3,362,000
inventory	71,688,000	65,581,000	78,509,000	75,987,000	83,981,000	93,988,000	89,146,000	95,771,000	100,453,000	131,879,000	128,962,000	115,489,000	88,976,000	78,516,000	86,363,000	97,899,000	84,358,000	73,940,000	75,202,000	66,942,000	77,418,000	68,300,000	56,348,000	54,562,000	40,587,000	32,001,000	24,068,000	11,081,000
prepaid expenses and other current assets	147,314,000	152,420,000	116,964,000	145,350,000	154,745,000	201,960,000	126,382,000	157,958,000	145,452,000	119,030,000	132,916,000	125,516,000	129,778,000	115,065,000	88,078,000	108,534,000	94,136,000	75,980,000	62,767,000	74,766,000	88,349,000	98,698,000	80,343,000	73,536,000	65,616,000	81,674,000	73,713,000	90,843,000	51,932,000	66,665,000	40,120,000	30,430,000	22,033,000	18,127,000	21,744,000	19,282,000	22,152,000	27,626,000	16,559,000	17,453,000	15,117,000	13,206,000	9,739,000	10,699,000	10,270,000	8,409,000	3,910,000	4,776,000	4,205,000	3,542,000	2,540,000	5,679,000	6,933,000	7,252,000	4,158,000	4,909,000	5,077,000	4,919,000	6,889,000	6,432,000	6,021,000	5,109,000	4,151,000	5,173,000	5,327,000	5,454,000	4,674,000	4,523,000	4,182,000	1,922,000	2,926,000	4,125,000	1,575,000	1,057,000	1,695,000	1,706,000	2,199,000	1,729,000	1,657,000	1,301,000	1,238,000	988,000	966,000	1,345,000	1,413,000
total current assets	3,643,699,000	3,268,258,000	3,295,285,000	3,355,424,000	3,172,856,000	2,988,607,000	2,982,697,000	2,985,452,000	2,524,047,000	2,541,018,000	2,692,247,000	2,690,847,000	2,471,638,000	2,589,677,000	2,808,576,000	2,675,362,000	2,725,163,000	2,470,083,000	2,614,777,000	2,554,702,000	2,160,446,000	1,584,773,000	1,715,864,000	1,897,265,000	2,063,773,000	1,392,013,000	1,200,696,000	1,342,120,000	1,502,559,000	1,685,297,000	1,764,740,000	993,368,000	960,709,000	597,188,000	671,877,000	747,564,000	888,068,000	1,050,074,000	1,105,388,000	1,041,793,000	1,029,150,000	1,090,186,000	746,367,000	643,017,000	665,121,000	674,063,000	254,028,000	199,164,000	214,359,000	240,111,000	125,456,000	235,933,000	240,342,000	208,539,000	152,028,000	179,957,000	224,334,000	250,709,000	254,139,000	244,623,000	273,510,000	273,309,000	293,534,000	228,165,000	278,422,000	419,339,000	442,249,000	451,779,000	550,631,000	455,475,000	463,559,000	477,632,000	201,958,000	209,916,000	222,784,000	126,827,000	129,057,000	137,120,000	82,414,000	26,697,000	33,840,000	41,442,000		47,198,000	50,511,000
property, plant and equipment	499,791,000	498,684,000	502,784,000	506,997,000	517,159,000	523,460,000	526,057,000	525,591,000	527,474,000	523,032,000	523,494,000	514,821,000	508,201,000	504,389,000	501,958,000	484,941,000	470,700,000	464,572,000	465,029,000	444,690,000	439,126,000	429,814,000	425,179,000	396,456,000	371,769,000	341,712,000	320,658,000	272,652,000	227,839,000	201,979,000	181,900,000	161,899,000	147,533,000	129,962,000	114,572,000
operating lease right-of-use assets	192,401,000	197,233,000	191,148,000	196,408,000	198,303,000	195,468,000	199,732,000	203,485,000	208,801,000	215,049,000	215,136,000	218,802,000	223,921,000	228,769,000	231,675,000	235,853,000	238,089,000	237,213,000	241,485,000	245,234,000	229,674,000	221,280,000	221,197,000	223,444,000	226,357,000	226,412,000
deferred tax assets	104,363,000	107,224,000	116,863,000																																					9,406,000	19,654,000	33,667,000	31,667,000																	1,943,000	1,937,000	1,937,000	1,937,000	5,312,000	5,606,000	5,606,000	5,382,000
restricted investments	68,593,000	68,592,000	68,593,000	68,592,000	49,391,000	49,390,000	49,391,000	49,390,000	49,388,000	49,388,000	49,390,000	49,389,000	49,390,000	40,889,000	40,891,000	40,890,000	40,890,000	40,725,000	40,725,000	24,725,000	24,725,000	24,725,000	14,825,000	14,825,000	44,825,000	44,825,000	44,825,000	44,825,000	44,825,000	30,000,000	30,000,000	150,000,000	150,000,000	150,000,000	150,000,000	150,000,000	150,000,000
other assets	57,172,000	73,820,000	65,310,000	77,618,000	71,925,000	67,461,000	72,003,000	75,155,000	92,686,000	63,453,000	66,092,000	61,396,000	77,267,000	69,821,000	60,204,000	35,267,000	34,587,000	42,676,000	45,045,000	37,932,000	20,396,000	19,032,000	18,069,000	9,632,000	9,687,000	9,037,000	8,623,000	16,057,000	14,166,000	5,215,000	4,171,000	1,471,000	1,471,000	1,471,000	1,562,000	1,561,000	1,471,000	1,471,000	1,471,000												101,000																	89,000	116,000	145,000	173,000	201,000	685,000	749,000	803,000	351,000	416,000	508,000	550,000	428,000	457,000	485,000	514,000
total assets	4,566,019,000	4,213,811,000	4,239,983,000	4,205,039,000	4,009,634,000	3,824,386,000	3,829,880,000	3,839,073,000	3,402,396,000	3,391,940,000	3,546,359,000	3,535,255,000	3,330,417,000	3,433,545,000	3,643,304,000	3,472,313,000	3,509,429,000	3,255,269,000	3,407,061,000	3,307,283,000	3,374,367,000	2,279,624,000	2,395,134,000	2,541,622,000	2,716,411,000	2,013,999,000	1,574,802,000	1,675,654,000	1,789,389,000	1,923,139,000	1,994,730,000	1,358,281,000	1,434,283,000	1,133,926,000	1,262,810,000	1,312,910,000	1,382,162,000	1,316,949,000	1,386,510,000	1,436,144,000	1,530,771,000	1,628,790,000	1,079,595,000	986,357,000	1,032,659,000	1,080,297,000	420,530,000	447,503,000	462,558,000	471,578,000	287,520,000	322,352,000	318,477,000	340,295,000	281,917,000	310,223,000	340,828,000	369,052,000	393,265,000	412,606,000	440,180,000	463,406,000	481,385,000	495,668,000	518,653,000	554,529,000	554,676,000	580,181,000	580,046,000	486,256,000	493,791,000	505,091,000	219,658,000	227,340,000	240,006,000	144,527,000	147,114,000	153,687,000	98,348,000	43,248,000	50,862,000	59,067,000		62,545,000	68,473,000
liabilities and stockholders' equity
current liabilities:
accounts payable	102,393,000	97,399,000	88,415,000	70,805,000	73,980,000	78,148,000	55,519,000	73,840,000	59,746,000	62,237,000	98,094,000	40,572,000	52,418,000	54,916,000	73,426,000	40,048,000	53,079,000	45,381,000	51,966,000	27,872,000	26,125,000	40,484,000	49,884,000	39,392,000	71,215,000	22,671,000	59,708,000	21,772,000	11,988,000	13,206,000	28,355,000	9,239,000	23,170,000	25,371,000	54,465,000	23,137,000	12,824,000	17,442,000	16,787,000	14,272,000	15,715,000	15,486,000	15,111,000	5,201,000	6,168,000	5,037,000	5,896,000	2,728,000	4,534,000	3,105,000	4,420,000	5,093,000	5,519,000	4,339,000	5,800,000	5,486,000	7,949,000	5,800,000	9,312,000	6,561,000	10,398,000	6,988,000	12,489,000	8,426,000	6,463,000	8,729,000	2,588,000	3,342,000	6,240,000	9,084,000	3,826,000	7,057,000	5,669,000	3,007,000	4,085,000	2,456,000	3,698,000	3,928,000	1,975,000	1,985,000	1,612,000	1,653,000	910,000	1,450,000	1,810,000
accrued expenses	918,966,000	704,165,000	887,472,000	946,168,000	808,643,000	698,865,000	713,013,000	713,094,000	598,530,000	508,599,000	545,460,000	510,579,000	421,243,000	355,936,000	395,174,000	388,576,000	341,187,000	280,527,000	355,909,000	295,260,000	211,186,000	183,221,000	197,201,000	177,948,000	138,800,000	106,873,000	112,719,000	93,564,000	89,867,000	63,824,000	72,203,000	51,260,000	43,820,000	31,842,000	42,118,000	36,211,000	37,551,000	30,805,000	28,798,000	18,444,000	17,758,000	14,427,000	23,680,000	19,799,000	15,783,000	16,600,000	14,160,000	15,386,000	8,488,000	9,086,000	11,558,000	14,914,000	14,228,000	13,006,000	12,340,000	12,230,000	11,380,000	12,050,000	11,116,000	10,880,000	7,425,000	8,754,000	9,833,000	8,381,000	9,908,000	10,389,000	9,328,000	9,859,000	9,497,000	9,666,000	11,724,000	11,746,000	9,980,000	7,297,000	4,479,000	5,104,000	4,583,000	3,669,000	3,899,000
operating lease liabilities	46,097,000	46,011,000	41,886,000
deferred revenue	15,080,000	28,160,000	55,481,000	71,030,000	69,009,000	76,850,000	102,753,000	77,140,000	54,639,000	35,794,000	42,105,000	144,208,000	114,292,000	131,838,000	149,483,000	115,044,000	98,144,000	116,340,000	127,207,000	114,601,000	107,587,000	86,043,000	77,821,000	107,359,000	89,242,000	2,642,000	3,496,000	3,444,000	9,161,000	35,855,000	41,705,000	38,532,000	39,794,000	36,755,000	33,540,000	21,087,000	18,885,000	16,944,000	15,352,000	13,973,000	12,460,000	14,099,000	23,871,000	30,270,000	27,002,000	29,121,000	32,696,000	33,558,000	33,560,000	33,548,000	31,417,000	31,156,000	35,345,000	48,410,000	62,366,000	75,727,000	80,721,000	81,010,000	81,134,000	81,270,000	83,100,000	81,893,000	81,929,000	82,420,000	82,570,000	82,539,000	79,864,000	80,048,000	80,806,000	58,822,000	59,249,000	61,652,000	7,840,000	9,899,000	11,144,000	10,924,000	9,599,000	10,387,000	10,734,000	1,266,000	1,390,000	1,519,000	1,000,000	1,071,000	1,451,000
liability related to the sale of future royalties	97,523,000	81,793,000	113,018,000	90,516,000	61,963,000	46,174,000	54,991,000	44,195,000	33,650,000	23,706,000	40,289,000	35,851,000	28,496,000	21,983,000	37,079,000	26,376,000	22,876,000	13,660,000	13,316,000	10,316,000	5,957,000
development derivative liability	120,788,000	118,095,000
total current liabilities	1,300,847,000	1,075,623,000	1,186,272,000	1,220,663,000	1,055,251,000	941,709,000	967,786,000	949,785,000	788,639,000	673,391,000	767,915,000	772,791,000	657,685,000	605,963,000	695,710,000	610,656,000	554,648,000	494,825,000	585,270,000	480,241,000	384,302,000	338,791,000	352,594,000	352,864,000	328,604,000	149,163,000	179,494,000	121,503,000	113,659,000	115,383,000	144,251,000	101,045,000	108,726,000	95,786,000	131,699,000	81,761,000	70,575,000	66,369,000	62,099,000	57,112,000	66,598,000	80,693,000	95,334,000	56,849,000	53,745,000	83,831,000	53,864,000	54,895,000	53,066,000	49,750,000	48,345,000	54,758,000	57,064,000	66,638,000	80,990,000	93,927,000	100,534,000	99,344,000	102,046,000	99,433,000	102,033,000	98,571,000	110,733,000	101,121,000	102,331,000	104,251,000	99,452,000	102,024,000	105,727,000	84,910,000	82,091,000	87,456,000	27,106,000	23,498,000	22,925,000	21,530,000	20,601,000	19,990,000	18,484,000	8,002,000	9,021,000	6,138,000		6,640,000	8,704,000
operating lease liabilities, net of current portion	224,445,000	230,061,000	229,541,000
convertible debt	1,026,522,000	1,025,566,000	1,024,621,000	1,023,654,000	1,022,688,000	1,021,732,000	1,020,776,000	1,019,809,000	1,018,843,000	1,017,887,000	1,016,942,000	1,015,975,000
liability related to the sale of future royalties, net of current portion	1,345,147,000	1,338,821,000	1,334,353,000	1,333,849,000	1,342,580,000	1,336,892,000	1,322,248,000	1,310,814,000	1,298,446,000	1,285,200,000	1,252,015,000	1,231,873,000	1,214,311,000	1,193,822,000	1,151,024,000	1,132,362,000	1,105,685,000	1,086,065,000	1,058,225,000	1,032,708,000	1,008,336,000
development derivative liability, net of current portion	407,535,000	422,434,000
other liabilities	10,932,000	5,871,000	398,108,000	357,477,000	350,428,000	319,990,000	308,438,000	280,734,000	257,054,000	224,046,000	212,580,000	183,001,000	157,301,000	120,828,000	98,963,000	76,450,000	71,633,000	60,461,000	37,908,000	16,341,000	18,855,000	9,198,000	9,330,000	9,036,000	9,514,000	5,072,000	4,965,000	4,335,000	4,186,000	4,458,000	4,347,000	2,842,000	2,815,000	3,184,000	3,067,000	1,991,000	1,777,000	1,373,000	1,301,000					500,000	1,000,000	1,000,000
total liabilities	4,315,428,000	4,098,376,000	4,172,895,000	4,172,685,000	4,012,701,000	4,043,658,000	4,050,524,000	4,004,939,000	3,810,527,000	3,651,180,000	3,704,582,000	3,602,893,000	3,154,377,000	3,032,379,000	3,055,101,000	2,716,420,000	2,656,067,000	2,329,079,000	2,390,814,000	2,092,260,000	1,974,641,000	929,895,000	956,442,000	934,535,000	959,216,000	467,013,000	272,837,000	197,535,000	168,587,000	168,334,000	228,299,000	299,446,000	311,317,000	303,025,000	342,589,000	297,942,000	283,680,000	127,898,000	121,796,000	114,540,000	122,167,000	132,280,000	143,328,000	81,879,000	90,390,000	125,324,000	150,183,000	149,921,000	154,383,000	160,022,000	153,467,000	145,192,000	130,190,000	142,917,000	163,920,000	182,350,000	204,277,000	223,485,000	235,032,000	251,963,000	274,702,000	291,576,000	303,420,000	313,647,000	334,171,000	355,785,000	352,551,000	375,624,000	380,877,000	283,444,000	294,623,000	312,156,000	40,388,000	37,313,000	38,832,000	39,750,000	37,037,000	35,771,000	36,569,000	20,177,000	21,474,000	19,238,000		17,564,000	17,798,000
commitments and contingencies
stockholders' equity:
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of june 30, 2025 and december 31, 2024
common stock	1,310,000	1,303,000	1,293,000	1,289,000	1,281,000	1,265,000	1,259,000	1,255,000	1,250,000	1,243,000	1,240,000	1,230,000	1,210,000	1,207,000	1,202,000	1,195,000	1,186,000	1,173,000	1,164,000	1,161,000	1,156,000	1,131,000	1,122,000	1,113,000	1,110,000	1,064,000	1,011,000	1,009,000	1,005,000	1,005,000	997,000	924,000	917,000	861,000	859,000	858,000	856,000	855,000	851,000	847,000	845,000	842,000	772,000	767,000	763,000	755,000	637,000	632,000	624,000	621,000	525,000	524,000	520,000	519,000	427,000	427,000	427,000	424,000	423,000	422,000	421,000	419,000	418,000	418,000	417,000	414,000	414,000	414,000	411,000	408,000	408,000	406,000	376,000	375,000	371,000	322,000	321,000	320,000	267,000	212,000	209,000	209,000		201,000	200,000
additional paid-in capital	7,690,737,000	7,496,876,000	7,388,061,000	7,259,876,000	7,122,704,000	6,881,977,000	6,811,063,000	6,736,939,000	6,647,173,000	6,522,091,000	6,454,540,000	6,336,771,000	6,172,990,000	6,116,558,000	6,058,453,000	5,968,661,000	5,863,476,000	5,747,394,000	5,644,074,000	5,592,884,000	5,520,320,000	5,289,966,000	5,201,176,000	5,091,248,000	5,034,284,000	4,601,662,000	4,175,139,000	4,140,033,000	4,037,853,000	4,009,342,000	3,947,552,000	3,097,110,000	3,038,529,000	2,627,969,000	2,609,614,000	2,585,765,000	2,565,728,000	2,546,884,000	2,506,197,000	2,483,958,000	2,468,187,000	2,450,690,000	1,843,362,000	1,823,766,000	1,810,775,000	1,776,366,000	846,228,000	833,660,000	813,613,000	806,137,000	624,876,000	621,350,000	613,149,000	609,260,000	518,731,000	514,290,000	509,826,000	504,793,000	500,443,000	495,350,000	490,558,000	482,743,000	476,663,000	471,755,000	465,277,000	457,838,000	452,767,000	448,092,000	440,410,000	428,990,000	424,453,000	420,039,000	353,221,000	351,252,000	340,779,000	236,416,000	235,264,000	234,057,000	170,033,000	117,176,000	112,902,000	112,158,000	112,216,000	106,403,000	107,526,000
accumulated other comprehensive loss	-29,952,000	-37,517,000	-34,518,000	-24,826,000	-34,637,000	-26,988,000	-23,375,000	-32,339,000	-37,080,000	-39,124,000	-44,654,000	-43,783,000	-42,224,000	-38,065,000	-33,259,000	-34,230,000	-36,081,000	-36,717,000	-43,622,000	-37,193,000	-33,212,000	-32,059,000	-36,518,000	-34,371,000	-35,831,000	-32,853,000	-33,213,000	-33,392,000	-33,807,000	-34,853,000	-34,433,000	-33,741,000	-33,959,000	-33,828,000																			-62,000	-37,000																								-71,000
accumulated deficit	-7,411,504,000	-7,345,227,000	-7,287,748,000	-7,203,985,000	-7,092,415,000	-7,075,526,000	-7,009,591,000	-6,871,721,000	-7,019,474,000	-6,743,450,000	-6,569,349,000	-6,361,856,000	-5,955,936,000	-5,678,534,000	-5,438,193,000	-5,179,733,000	-4,975,219,000	-4,785,660,000	-4,585,369,000	-4,341,829,000	-4,088,538,000	-3,909,309,000	-3,727,088,000	-3,450,903,000	-3,242,368,000	-3,022,887,000	-2,840,972,000	-2,629,531,000	-2,384,249,000	-2,220,689,000	-2,147,685,000	-2,005,458,000	-1,882,521,000	-1,764,101,000	-1,656,811,000	-1,543,877,000	-1,439,806,000	-1,349,677,000	-1,246,703,000	-1,155,982,000	-1,079,190,000	-1,007,407,000	-956,630,000	-935,241,000	-891,252,000	-847,178,000	-596,235,000	-563,878,000	-534,192,000	-516,023,000	-507,010,000	-444,822,000	-425,320,000	-412,364,000	-400,996,000	-386,693,000	-373,456,000	-359,632,000	-343,347,000	-336,417,000	-326,787,000	-312,155,000	-299,832,000	-292,041,000	-282,833,000	-260,131,000	-252,242,000	-242,850,000	-239,992,000	-227,232,000	-225,993,000	-227,655,000	-174,863,000	-162,171,000	-140,527,000	-132,089,000	-124,689,000	-114,779,000	-105,919,000	-91,428,000	-80,750,000	-69,604,000	-63,005,000	-57,305,000	-50,889,000
total stockholders' equity	250,591,000	115,435,000
total liabilities and stockholders' equity	4,566,019,000	4,213,811,000
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of march 31, 2025 and december 31, 2024
liabilities and stockholders’ equity
deferred revenue, net of current portion				1,012,000	2,402,000	185,506,000	188,175,000	196,086,000	194,129,000	191,257,000	193,791,000	132,930,000	175,341,000	157,668,000	152,360,000	177,123,000	202,391,000	208,123,000	225,094,000	265,708,000	281,530,000	306,124,000	318,383,000	296,179,000	313,887,000	478,000	458,000	1,623,000	4,522,000	7,676,000	43,075,000	38,356,000	42,079,000	46,049,000	49,392,000	55,894,000	54,810,000	53,952,000	52,965,000	52,117,000	50,256,000	46,566,000	42,983,000	20,028,000	32,548,000	37,674,000	93,394,000	91,779,000	97,636,000	105,980,000	100,874,000	85,029,000	68,108,000	72,374,000	78,487,000	84,810,000	100,122,000	120,200,000	129,974,000	149,666,000	169,958,000	190,248,000	189,884,000	209,677,000	229,669,000	248,959,000	250,121,000	269,441,000	268,868,000	191,440,000	204,067,000	217,051,000	5,105,000	5,655,000	6,786,000	8,473,000	6,685,000	8,070,000	10,099,000
stockholders’ equity
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of december 31, 2024 and december 31, 2023
total stockholders’ equity			67,088,000	32,354,000									176,040,000	401,166,000	588,203,000	755,893,000	853,362,000	926,190,000	1,016,247,000	1,215,023,000	1,399,726,000	1,349,729,000	1,438,692,000	1,607,087,000	1,757,195,000	1,546,986,000	1,301,965,000	1,478,119,000	1,620,802,000	1,754,805,000	1,766,431,000	1,058,835,000	1,122,966,000	830,901,000	920,221,000	1,014,968,000	1,098,482,000	1,189,051,000	1,264,714,000	1,321,604,000	1,408,604,000	1,496,510,000	936,267,000	904,478,000	942,269,000	954,973,000	270,347,000	297,582,000	308,175,000	311,556,000	134,053,000	177,160,000	188,287,000	197,378,000	117,997,000	127,873,000	136,551,000	145,567,000	158,233,000	160,643,000	165,478,000	171,830,000	177,965,000	182,021,000	184,482,000	198,744,000	202,125,000	204,557,000	199,169,000	202,812,000	199,168,000	192,935,000	179,270,000	190,027,000	201,174,000	104,777,000	110,077,000	117,916,000	61,779,000	23,071,000	29,388,000	39,829,000		44,981,000	50,675,000
total liabilities and stockholders’ equity			4,239,983,000	4,205,039,000									3,330,417,000	3,433,545,000	3,643,304,000	3,472,313,000	3,509,429,000	3,255,269,000	3,407,061,000	3,307,283,000	3,374,367,000	2,279,624,000	2,395,134,000	2,541,622,000	2,716,411,000	2,013,999,000	1,574,802,000	1,675,654,000	1,789,389,000	1,923,139,000	1,994,730,000	1,358,281,000	1,434,283,000	1,133,926,000	1,262,810,000	1,312,910,000	1,382,162,000	1,316,949,000	1,386,510,000	1,436,144,000	1,530,771,000	1,628,790,000	1,079,595,000	986,357,000	1,032,659,000	1,080,297,000	420,530,000	447,503,000	462,558,000	471,578,000	287,520,000	322,352,000	318,477,000	340,295,000	281,917,000	310,223,000	340,828,000	369,052,000	393,265,000	412,606,000	440,180,000	463,406,000	481,385,000	495,668,000	518,653,000	554,529,000	554,676,000	580,181,000	580,046,000	486,256,000	493,791,000	505,091,000	219,658,000	227,340,000	240,006,000	144,527,000	147,114,000	153,687,000	98,348,000	43,248,000	50,862,000	59,067,000
operating lease liability				42,144,000	41,656,000	41,672,000	41,510,000	41,516,000	42,074,000	43,055,000	41,967,000	41,581,000	41,236,000	41,290,000	40,548,000	40,612,000	39,362,000	38,917,000	36,872,000	32,192,000	33,447,000	29,043,000	27,688,000	28,165,000	29,347,000	16,977,000
operating lease liability, net of current portion				236,030,000	239,352,000	237,829,000	243,101,000	247,711,000	253,416,000	259,399,000	261,339,000	266,323,000	272,016,000	277,388,000	281,347,000	286,030,000	288,559,000	288,015,000	293,039,000	297,262,000	281,618,000	275,782,000	276,135,000	276,456,000	277,211,000	282,300,000
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of september 30, 2024 and december 31, 2023
liabilities and stockholders’ deficit
stockholders’ deficit:
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of june 30, 2024 and december 31, 2023
total stockholders’ deficit					-3,067,000	-219,272,000	-220,644,000	-165,866,000	-408,131,000	-259,240,000
total liabilities and stockholders’ deficit					4,009,634,000	3,824,386,000	3,829,880,000	3,839,073,000	3,402,396,000	3,391,940,000
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of march 31, 2024 and december 31, 2023
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of december 31, 2023 and december 31, 2022
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of september 30, 2023 and december 31, 2022
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of june 30, 2023 and december 31, 2022
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of march 31, 2023 and december 31, 2022
liabilities and stockholders’ (deficit) equity
long-term debt													677,723,000	676,710,000	675,697,000	433,799,000	433,151,000	191,590,000	191,278,000						30,000,000	30,000,000	30,000,000	30,000,000	30,000,000	30,000,000	30,000,000	150,000,000	150,000,000	150,000,000	150,000,000	150,000,000	150,000,000
stockholders’ (deficit) equity:
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of december 31, 2022 and december 31, 2021
total stockholders’ (deficit) equity											-158,223,000	-67,638,000
total liabilities and stockholders’ (deficit) equity											3,546,359,000	3,535,255,000
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of september 30, 2022 and december 31, 2021
stockholders’ equity:
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of june 30, 2022 and december 31, 2021
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of march 31, 2022 and december 31, 2021
receivable related to the sale of future royalties																	500,000,000	500,000,000	500,000,000	500,000,000	500,000,000
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of december 31, 2021 and december 31, 2020
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of september 30, 2021 and december 31, 2020
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of june 30, 2021 and december 31, 2020
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of march 31, 2021 and december 31, 2020
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of december 31, 2020 and december 31, 2019
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of september 30, 2020 and december 31, 2019
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of june 30, 2020 and december 31, 2019
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of march 31, 2020 and december 31, 2019
deferred rent																											3,571,000	2,723,000	2,643,000	2,498,000	1,988,000	2,014,000	1,942,000	1,818,000	1,576,000	1,326,000	1,315,000	1,178,000	1,162,000	1,017,000	1,011,000	1,010,000	1,005,000	723,000	711,000	869,000	1,112,000	1,200,000	1,252,000	988,000	950,000	840,000	608,000	608,000	484,000	484,000	484,000	484,000	484,000	485,000	838,000	838,000	838,000	837,000	1,561,000	1,561,000	1,561,000	1,561,000	5,074,000	4,853,000	5,200,000	3,120,000	3,271,000	3,095,000	3,202,000	3,310,000	3,417,000	2,391,000	2,467,000	2,574,000	2,682,000	2,789,000	2,896,000
deferred rent, net of current portion																											57,920,000	40,074,000	16,220,000	10,817,000	6,626,000	7,203,000	7,697,000	8,006,000	8,431,000	8,296,000	6,518,000	6,204,000	5,431,000	5,311,000	5,313,000	5,021,000	5,011,000	4,502,000	3,097,000	2,819,000	2,925,000	3,247,000	3,681,000	4,292,000	4,248,000	4,884,000	4,328,000	3,202,000	3,727,000	2,884,000	2,879,000	2,874,000	2,869,000	2,864,000	2,543,000	2,576,000	2,609,000	2,642,000	1,951,000	2,342,000	2,732,000	3,122,000
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of december 31, 2019 and december 31, 2018
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding as of september 30, 2019 and december 31, 2018
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding at june 30, 2019 and december 31, 2018
preferred stock, 0.01 par value per share, 5,000 shares authorized and no shares issued and outstanding at march 31, 2019 and december 31, 2018
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2018 and 2017
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2018 and december 31, 2017
billed and unbilled collaboration receivables																													2,961,000	50,768,000	34,002,000	14,644,000	15,405,000	19,457,000	23,334,000	15,146,000	9,514,000	8,814,000	8,298,000	8,130,000	9,403,000	10,107,000	39,937,000	384,000	89,000	164,000	4,248,000	609,000	460,000	558,000	104,000	1,918,000	4,385,000	2,192,000	1,468,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2018 and december 31, 2017
marketable securities																														1,171,715,000	1,045,257,000	746,249,000	514,600,000	385,843,000	424,185,000	531,041,000	571,994,000	748,422,000	848,217,000	828,427,000	788,740,000	660,403,000	526,929,000	507,927,000	524,585,000	314,901,000	192,701,000	181,939,000	184,719,000	138,207,000	71,407,000	152,498,000	180,750,000	137,356,000	76,174,000	98,685,000	150,839,000	154,050,000	158,532,000	184,486,000	193,012,000	146,811,000	143,934,000	119,883,000	119,368,000	180,786,000	238,596,000	223,379,000	290,787,000	247,592,000	350,445,000	267,831,000	110,304,000	137,804,000	89,305,000	84,758,000	87,622,000	75,471,000	64,245,000	17,631,000	22,477,000	26,075,000		30,393,000	14,207,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2018 and december 31, 2017
investment in equity securities of regulus therapeutics inc.																																		2,682,000	8,997,000	13,614,000	13,332,000	33,934,000	51,419,000	38,565,000	64,628,000	99,890,000		41,286,000	49,450,000	55,478,000	45,452,000	57,999,000	60,336,000	47,666,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2017 and 2016
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2017 and december 31, 2016
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2017 and december 31, 2016
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2017 and december 31, 2016
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2016 and 2015
accumulated other comprehensive income																																			-33,441,000	-27,778,000	-28,296,000	-9,011,000	4,369,000	-7,219,000	18,762,000	52,385,000	48,763,000	15,186,000	21,983,000	25,030,000	19,717,000	27,168,000	28,130,000	20,821,000	15,662,000				-165,000	-151,000	-246,000	-18,000	714,000	1,288,000	1,286,000	823,000	716,000	1,889,000	1,621,000	623,000	1,186,000	-1,099,000	-1,660,000	646,000	300,000	145,000	558,000	624,000	640,000				-142,000	-32,000	-32,000	191,000	420,000	41,000	-37,000
property and equipment																																				74,219,000	55,394,000	36,814,000	27,812,000	26,316,000	25,169,000	21,166,000	21,740,000	18,806,000	16,953,000	15,731,000	16,448,000	16,974,000	18,045,000	18,983,000	19,799,000	18,792,000	14,206,000	13,703,000	14,643,000	15,309,000	16,252,000	17,021,000	18,289,000	18,399,000	18,554,000	18,304,000	18,324,000	18,152,000	18,483,000	19,321,000	19,194,000	19,577,000	18,853,000	15,875,000	13,810,000	10,434,000	12,965,000	12,527,000	12,173,000				10,580,000				11,694,000	8,969,000	11,436,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2016 and december 31, 2015
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2016 and december 31, 2015
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2016 and december 31, 2015
deferred tax liabilities																																								9,406,000	19,654,000	33,667,000	31,667,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2015 and 2014
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2015 and december 31, 2014
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2015 and december 31, 2014
accrued intraperiod tax allocation																																										2,004,000		856,000	4,081,000	6,825,000		2,023,000	5,232,000	3,023,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2015 and december 31, 2014
investment in equity securities of regulus therapeutics inc																																											94,583,000								38,748,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2014 and 2013
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2014 and december 31, 2013
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2014 and december 31, 2013
liability for stock issuance																																														25,379,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2014 and december 31, 2013
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2013 and 2012
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2013 and december 31, 2012
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2013 and december 31, 2012
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2013 and december 31, 2012
other long-term liabilities																																																				521,000	690,000	703,000	716,000	729,000	742,000	1,067,000	143,000		168,000	181,000	194,000	207,000	220,000	233,000	246,000	318,000	270,000	286,000	302,000	583,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2012 and 2011
investment in joint venture																																																							564,000	1,421,000	1,801,000	2,709,000	3,616,000	20,000	1,183,000	5,032,000	6,435,000	7,867,000	8,901	9,713,000	1,583,000	4,699,000	6,412,000	7,684,000	9,129,000	9,901,000
intangible assets																																																				145,000	188,000	231,000	275,000	318,000	361,000	405,000	448,000	491,000	535,000	578,000	622,000	665,000	708,000	751,000	795,000	838,000	882,000	925,000	968,000	1,610,000	1,737,000	1,835,000	1,933,000				2,491,000				3,405,000	3,523,000	3,642,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2012 and december 31, 2011
accumulated other comprehensive gain																																																				108,000																								263,000	113,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2012 and december 31, 2011
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2012 and december 31, 2011
income taxes receivable																																																											10,669,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2011 and 2010
collaboration receivables																																																								2,027,000	1,308,000	1,150,000	3,450,000	4,881,000	6,358,000	4,505,000	6,044,000	5,022,000	5,857,000	5,831,000	4,188,000	24,140,000	5,126,000	9,680,000	5,031,000	5,129,000	5,615,000	4,393,000	3,829,000	4,847,000	3,591,000	3,116,000	609,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2011 and december 31, 2010
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2011 and december 31, 2010
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2011 and december 31, 2010
deferred tax assets, net of current portion																																																												8,570,000	8,674,000	8,674,000	8,556,000
income taxes payable																																																												237,000	272,000	98,000	5,644,000	1,057,000	1,829,000	1,033,000	6,111,000	3,987,000	5,216,000	3,450,000	3,497,000	3,296,000
preferred stock, 0.01 par value per share, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2010 and 2009
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2010 and december 31, 2009
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2010 and december 31, 2009
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2010 and december 31, 2009
restricted cash																																																																			2,999,000	3,000,000	3,000,000	6,152,000	6,152,000	5,313,000	2,313,000	2,313,000	2,313,000	2,313,000	2,313,000	2,313,000	2,313,000	2,313,000	2,313,000	2,313,000
restricted cash, net of current portion																																																																		3,152,000	3,152,000	3,152,000	3,152,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2009 and 2008
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2009 and december 31, 2008
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2009 and december 31, 2008
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2009 and december 31, 2008
current portion of notes payable																																																																				3,227,000	3,968,000	3,888,000	3,795,000	3,705,000	3,617,000	3,295,000	3,217,000	3,046,000	2,721,000	2,006,000
notes payable, net of current portion																																																																				719,000	938,000	1,955,000	2,963,000	3,946,000	4,906,000	5,065,000	5,919,000	6,437,000	6,334,000	5,320,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2008 and 2007
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2008 and december 31, 2007
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2008 and december 31, 2007
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2008 and december 31, 2007
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2007 and 2006
deferred stock-based compensation
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at september 30, 2007 and december 31, 2006
deferred stock compensation																																																																									-22,000	-53,000	-89,000	-135,000	-932,000	-1,611,000	-2,460,000	-2,857,000	-2,941,000	-3,125,000	-3,697,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2007 and december 31, 2006
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2007 and december 31, 2006
related party notes receivable																																																																															146,000	283,000	281,000	297,000	310,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2006 and december 31, 2005
property and equipment, net of accumulated depreciation of 7,732 and 5,097 at september 30, 2006 and december 31, 2005, respectively																																																																												12,856,000
intangible assets, net of accumulated amortization of 1,454 and 1,143 at september 30, 2006 and december 31, 2005, respectively																																																																												2,180,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding as of september 30, 2006 and december 31, 2005
property and equipment, net of accumulated depreciation of 6,764 and 5,097 at june 30, 2006 and december 31, 2005, respectively																																																																													13,044,000
intangible assets, net of accumulated amortization of 1,350 and 1,143 at june 30, 2006 and december 31, 2005, respectively																																																																													2,284,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2006 and december 31, 2005
property and equipment, net of accumulated depreciation of 5,862 and 5,097 at march 31, 2006 and december 31, 2005, respectively																																																																														11,359,000
intangible assets, net of accumulated amortization of 1,247 and 1,143 at march 31, 2006 and december 31, 2005, respectively																																																																														2,387,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2006 and december 31, 2005
current portion of note payable																																																																															1,876,000	1,765,000	1,776,000	1,288,000	790,000	379,000
note payable, net of current portion																																																																															5,519,000	5,782,000	6,187,000	6,478,000	6,411,000	6,591,000	5,705,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at december 31, 2005 and december 31, 2004
collaboration receivable																																																																																304,000		1,867,000	859,000	916,000	3,000,000
property and equipment, net of accumulated depreciation of 4,403 and 2,463 at september 30, 2005 and december 31, 2004, respectively																																																																																10,760,000
intangible assets, net of accumulated amortization of 1,025 and 670 at september 30, 2005 and december 31, 2004, respectively																																																																																3,050,000
accrued liabilities																																																																																2,986,000	4,243,000	1,678,000	3,875,000	3,740,000	5,443,000
preferred stock, 0.01 par value, 5,000,000 shares authorized; no shares issued or outstanding as of september 30, 2005 or december 31, 2004
collaboration and license receivables																																																																																	679,000
property and equipment, net of accumulated depreciation of 3,704 and 2,464 at june 30, 2005 and december 31, 2004, respectively																																																																																	11,084,000
intangible assets, net of accumulated amortization of 907 and 670 at june 30, 2005 and december 31, 2004, respectively																																																																																	3,168,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at june 30, 2005 and no shares authorized, issued or outstanding at december 31, 2004
property and equipment, net of accumulated depreciation of 3,063 and 2,463 at march 31, 2005 and december 31, 2004, respectively																																																																																		11,540,000
intangible assets, net of accumulated amortization of 788 and 670 at march 31, 2005 and december 31, 2004, respectively																																																																																		3,287,000
preferred stock, 0.01 par value, 5,000,000 shares authorized and no shares issued and outstanding at march 31, 2005 and december 31, 2004
liabilities, redeemable convertible preferred stock and stockholders’ equity
redeemable convertible preferred stock
deferred financing costs																																																																																				542,000	571,000
deferred compensation																																																																																				-4,359,000	-6,125,000
total liabilities, redeemable convertible preferred stock and stockholders’ equity																																																																																				62,545,000	68,473,000
current assets
current liabilities

We provide you with 20 years of balance sheets for Alnylam Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Alnylam Pharmaceuticals. Explore the full financial landscape of Alnylam Pharmaceuticals stock with our expertly curated balance sheets.

The information provided in this report about Alnylam Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.